| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W |
| P698 | PubMed publication ID | 10940896 |
| P2093 | author name string | Aarden L | |
| Schapira M | |||
| Hart M | |||
| Rüegg M | |||
| Duchosal MA | |||
| Fuzzati-Armentero MT | |||
| Mauray S | |||
| Nicoloso G | |||
| Trouillet P | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 2065-2073 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6. | |
| P478 | volume | 30 |
| Q38907078 | A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting. |
| Q24648532 | Chronic immune activation and inflammation as the cause of malignancy |
| Q34554736 | Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer |
| Q42154744 | Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas. |
| Q40483193 | Effect of plasma exchange on the circulating IL-6 levels in a patient with fatal hemophagocytic syndrome associated with bile ductopenia |
| Q34123985 | Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model |
| Q44368783 | Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new disease. |
| Q34668808 | Identification of a sub-population of B cells that proliferates after infection with Epstein-Barr virus |
| Q35017852 | Immunological aspects of Epstein-Barr virus infection |
| Q34387624 | Impact of interleukin-6 in hematological malignancies |
| Q38186778 | Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence? |
| Q42248755 | Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial. |
| Q35026045 | Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders |
| Q40725509 | Regulation of TIMP-1 phenotypic expression in Epstein--Barr virus-immortalized B lymphocytes |
| Q33650689 | Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disorders |
Search more.